Question 330 of 433
Are psychedelic therapies available?
The short answer
Not yet as approved medicine in the United States, though psilocybin is close.
The FDA declined to approve MDMA-assisted therapy for trauma in 2024 and asked for more study. A psilocybin treatment for resistant depression succeeded in two late-stage trials and is being submitted to the FDA, with a decision possible in 2027. For now, legal supervised use exists only in a few state programs, such as those in Oregon and Colorado. Retreats and underground sessions carry real psychiatric and cardiac risks, and I would not recommend them to a patient with heart disease.
“This book is for education. It is not medical advice, and reading it does not make you my patient or create a doctor-patient relationship.” From the book’s medical disclaimer. Full disclaimer
LATE-STAGE HUMAN RESEARCH — Selected psychiatric conditions: promising supervised protocols; authorization and access remain jurisdiction-specific.Evidence grade (draft mapping)Grade pendingPart 22, Q330 · Part sources
From Longevity Unmasked by Afshine Ash Emrani, MD, FACC. Medical disclaimer. This book is for education. It is not medical advice, and reading it does not make you my patient or create a doctor-patient relationship. Nothing here is meant to diagnose, treat, cure, or prevent any disease. Medicine is personal: a test, drug, supplement, or exercise plan that helps one person can harm another. Do not start, stop, or change any medication or treatment because of something you read in these pages. Talk with a licensed clinician who knows your history first. If you think you are having a medical emergency, call 911. The author disclaims responsibility for any loss or harm arising from use of the information in this book.